Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry

Academic Medicine

Volumn 79, Issue 11, 2004, Pages 1033-1040

  Wazana, Ashley ^a   Granich, Annette ^b   Primeau, François ^c,d   Bhanji, Nadeem H ^b   Jalbert, Maya ^e  

^a Ctr Hosp Vallee de l'Or Soins P   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e HÔPITAL CHARLES LEMOYNE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; EDUCATION PROGRAM; FINANCIAL MANAGEMENT; HEALTH PROGRAM; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL SCHOOL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRY; RESIDENCY EDUCATION; REVIEW;

EID: 13644251612     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001888-200411000-00004     Document Type: Review

References (45)

1. IMS Health, Integrated Promotional Services. Press-room: Top-line Industry data 〈http://www.imshealth.com/ims/portal/front/articleC/0,2777, 6599_44304752_44889690,00.html〉. Accessed 1 August 2004.
2. Zuger A. Fever pitch: getting doctors to prescribe is big business. The New York Times 1999 Jan 11; Sect. National Desk.
3. Physician Meeting and Event Audit, Scott Levin Inc. March 23, 2001 and May 2, 2001 press releases 〈http://www.scott_levin.com〉. Accessed 15 January 2004.
4. Wazana A. Ethical considerations in the relation between physicians and the pharmaceutical industry. Psychiatr Clin North Am. 2002;25:647-63.
5. McCormick BB, Tomlinson G, Brill-Edwards P, Detsky A. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA. 2001;286:1994-9.
6. Angell M. The pharmaceutical industry - to whom is it accountable? N Engl J Med. 2000;342:1902-4.
7. Gibbons RV, Landry FJ, Blouch DL, et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med. 1998;13:151-4.
8. Mainous III AG, Hueston WJ, Rich EC. Patients perceptions of physician acceptance of gifts from the pharmaceutical industry. Arch Fam Med. 1995;4:335-9.
9. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ. 1993;149:1401-7.
10. Wazana A. Is a gift ever just a gift? A critical review of the interaction between physicians and the pharmaceutical industry. JAMA. 2000;283:373-80.
11. Eckhart VF. Complimentary journeys to the World Congress of Gastroenterology - an inquiry of potential sponsors and beneficiaries. Zeitschr Gastroenterol. 2000;38:7-11.
12. Ferguson RP, Rhim E, Belizaire W, Egede L, Carter K, Lansdale T. Encounters with pharmaceutical sales representatives among practising internists. Am J Med. 1999;107:149-52.
13. Chakrabarti A, Fleisher W, Staley D, Calhoun L. Staff/resident interactions with the pharmaceutical industry: a survey of psychiatric training program policies. Paper delivered at the Canadian Psychiatric Association 50th Annual Meeting, October 2000, Victoria, Canada.
14. Sigworth SK, Cohen GM. Pharmaceutical branding of residents. JAMA. 2001;286:1024-5.
15. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-7.
16. Brotzman GL, Mark DH. The effect of resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med. 1993;8:130-4.
17. Sergeant MD, Hodgetts O, Godwin M, Walker DMC, McHenry P. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. CMAJ. 1996;155:1243-8.
18. Association of American Medical Colleges (Organization of Resident Representatives). Resident Physician and Medical Industry Interactions: Guiding Principles 〈http://www.aamc.org/members/orr/interactionguidelines. pdf〉. Accessed 4 March 2004.
19. Accreditation Council for Graduate Medical Education. Principles to Guide the Relationship between Graduate Medical Education and Industry. 〈http://www.acgme.org/New/GMEGuide.pdf〉. Accessed 4 March 2004.
20. American College of Physicians: Physicians and the pharmaceutical industry. Ann Intern Med. 1990;112:624-6.
21. American Medical Association. Gifts to physicians from industry. JAMA. 1991;265:501.
22. CMA policy summary: physicians and the pharmaceutical industry (update 1993). CMAJ. 1994;150:256A-256C.
23. Royal College of Physicians and Surgeons of Canada annual meeting committee. Guidelines for corporate participation in annual meetings. Ottawa, Canada: RCSPC, October 21, 1991.
24. Mahood S, Zagozeski C, Bradel T, Lawrence K. Pharmaceutical policies in Canadian family medicine training: survey of residency programs. Can Fam Physician. 1997;43:1947-51.
25. Reeder M, Dougherty J, White LJ. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993;22:105-8.
26. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ 1995;153:553-9.
27. Keim SM, Sanders AB, Witzke DB, Dyne P, Fulginiti JW. Beliefs and practices of emergency medicine faculty and residents regarding interactions with the biomedical industry. Ann Emerg Med. 1993;22:75-80.
28. McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693-7.
29. Brotzman GL, Mark DH. Policies regulating the activities of pharmaceutical representatives in residency programs. J Fam Pract. 1992;1:54-7.
30. Lichstein PR, Turner RC, O'Brien K. Impact of pharmaceutical company representatives on internal medicine residency programs. Arch Intern Med. 1992;152:1009-13.
31. Shear NH, Black F, Lexchin J Examining the physician-detailer interaction. Can J Clin Pharmacol. 1996;3:175-9.
32. Shaughnessy AF, Slawson DC, Bennett JH. Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med. 1995;27:581-5.
33. Daniel EE, Leedham L. Effect on student attitudes of a program of critical evaluation of claims for drugs. J Med Educ. 1966;41:49-60.
34. Palmisano P, Edelstein J. Teaching drug promotion abuses to health profession students. J Med Educ. 1980;55:453-5.
35. Ferguson RP. Training the resident to meet the detail men. JAMA. 1989;261:992-3.
36. Anastasio GD, Little JM. Pharmaceutical marketing: implications for medical residency training. Pharmacotherapy. 1996;16:103-7.
37. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont. CMAJ. 1993;149:403-4.
38. Somerset M, Weiss M, Farley T. Dramaturgical study of meetings between general practitioners and representatives of pharmaceutical companies. BMJ. 2001;323:1481-4.
39. Kelcher S, Brownoff R, Meadows LM. Structured approach to pharmaceutical representatives. Family medicine residency program. Can Fam Physician. 1998;44:1053-6, 1059-60.
40. Razack S, Arbour L, Hutcheon R. Proposed Model for Interaction Between Residents and Residency Training Programs, and Pharmaceutical Industry. Ann R Coll Phys Surg Can. 1999;32:93-103.
41. Royal College of Physicians and Surgeons of Canada. Bioethics for clinicians. Ann R Coll Phys Surg Can. 1999;32(suppl):S43-S68.
42. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston: Little, Brown and Company, 1991.
43. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behaviour of physicians. Am J Med. 1982;73:4-8.
44. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical representatives. JAMA. 1995;273:1296-8.
45. Guyatt G. Determining an ethical stance: pharmaceutical industry involvement and family medicine residency training. Can Fam Pract. 1997;43:1898-900.